1 Department of Biochemistry and Division of Disease Models, Center for Neural Disease and Cancer, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
2 Cell Signals, 75-1 Ono-cho, Tsurumi-ku, Yokohama 230-0046, Japan
3 Division of Molecular Neurobiology, National Institute for Basic Biology, Myodaiji-cho, Okazaki 444-8585, Japan
4 Department of Developmental Neuroscience, Tokyo Metropolitan Institute for Neuroscience, 2-6 Musashidai, Fuchu, Tokyo 183-8526, Japan
5 University of California Davis Medical Center, 4645 2nd Avenue, Sacramento, CA 95817, USA
* Author for correspondence (e-mail: tmurama{at}med.nagoya-u.ac.jp)
Accepted 29 July 2004
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: Cell migration, Growth factor, Integrin, LDL-receptor related protein, Midkine
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Here, we provide evidence that integrins serve as receptors for the growth factor midkine (MK) (Kadomatsu et al., 1988; Muramatsu, 2002a
; Muramatsu, 2002b
). MK is a 13 kDa protein with about 50% sequence identity to pleiotrophin (PTN), also called heparin-binding growth-associated molecule (HB-GAM) (Rauvala, 1989
; Li et al., 1990
), but is not related to other growth factors or cytokines. MK enhances the growth and survival of target cells and activates the transcription of certain genes (Muramatsu and Muramatsu, 1991
; Muramatsu et al., 1993
; Michikawa et al., 1993
; Nurcombe et al., 1993; Owada et al., 1999
; Sumi et al., 2002
). Furthermore, both MK and PTN/HB-GAM enhance the migration of various cells (Takada et al., 1997
; Imai et al., 1998
; Maeda and Noda, 1998
; Maeda et al., 1999
; Horiba et al., 2000
; Qi et al., 2001
). Of particular importance is the promotion of migration of inflammatory leukocytes (Takada et al., 1997
; Horiba et al., 2000
; Sato et al., 2001
). We have recently identified MK as a key molecule in the inflammatory response (Horiba et al., 2000
; Sato et al., 2001
). In MK-deficient mice, leukocyte infiltration into the blood vessels and kidney after ischemic injury is suppressed, leading to the suppression of neointima formation and nephritis after ischemia (Horiba et al., 2000
; Sato et al., 2001
). In the deficient mice, antibody-induced arthritis and intraperitoneal adhesions after surgery are also suppressed (Inoh et al., 2004
; Maruyama et al., 2004
).
So far, receptor-type protein tyrosine phosphatase (PTP
) (Maeda et al., 1999
), anaplastic lymphoma kinase (ALK) (Stoica et al., 2002
) and low-density-lipoprotein (LDL) receptor-related protein (LRP) (Muramatsu et al., 2000
) have been proposed as the MK receptors. PTP
is a chondroitin sulfate proteoglycan with an intracellular tyrosine phosphatase domain, an MK receptor for the migration of embryonic neurons (Maeda et al., 1999
) and osteoblast-like cells (Qi et al., 2001
), and involved in the survival of embryonic neurons (Sakaguchi et al., 2003
). PTP
is also a PTN receptor for the migration of embryonic neurons (Maeda et al., 1996
; Maeda and Noda, 1998
). ALK is a transmembrane tyrosine kinase (Iwahara et al., 1997
) and has been reported to serve as a PTN/HB-GAM and MK receptor primarily in the promotion of cell growth (Stoica et al., 2001
; Stoica et al., 2002
).
LRP is a member of the LDL-receptor family and is a receptor of MK necessary for the survival of embryonic neurons (Muramatsu et al., 2000). It also plays a role in the internalization of MK (Shibata et al., 2002
). Although the LDL-receptor family primarily serves as endocytosis receptors, some members have been found as components of signaling receptors (Herz and Bock, 2002
). Their role in the signaling of reelin (Howell et al., 1999
; Trommsdorff et al., 1999
) is of particular interest. Reelin is an extracellular-matrix (ECM) protein required for proper neuronal migration, and the reelin receptor is composed of three components: a member of the LDL-receptor family (VLDL receptor or apoE2 receptor) (Howell et al., 1999
; Trommsdorff et al., 1999
); cadherin-related neural receptor (Senzaki et al., 1999
); and
3ß1-integrin (Dulabon et al., 2000
). In addition, LRP5/6 function as components of the Wnt receptor complex (Tamai et al., 2000
; Wehrli et al., 2000
). LRP also associates with the platelet-derived growth factor (PDGF) receptor, leading to a downregulation of receptor activity (Boucher et al., 2003
).
In this communication, we provide evidence that 4ß1- and
6ß1-integrins bind directly to MK and are involved in MK-dependent cell migration and neurite outgrowth. Furthermore, we propose that integrins and other MK receptors mentioned above co-operate upon MK signaling, as in the case of reelin receptors.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Anti-PTP polyclonal antibody was prepared as described previously (Maeda et al., 1994
). Anti-PTP
monoclonal antibody (RPTPß) was purchased from BD PharMingen (San Diego, CA, USA), anti-hemagglutinin (anti-HA) was from Roche, anti-FLAG M2 monoclonal antibody, anti-
-tubulin and anti-FLAG M2 affinity gel were from Sigma (St Louis, MO, USA), anti-Myc antibody was from Upstate Biotechnology (Lake Placid, NY, USA) and anti-paxillin antibody was from BD Biosciences. Antibodies for western blotting were as follows: anti-
3-integrin (AB1920) and anti-ß1-integrin (MAB1965) were purchased from Chemicon International (Temecula, CA, USA), anti-
4-integrin (sc-6590), anti-
6-integrin (sc-6597) anti-ß4-integrin and anti-ß7-integrin were from Santa Cruz Biotechnology (Santa Cruz, CA, USA), anti-
5-integrin was from BD PharMingen, and anti-phosphotyrosine was from Upstate Biotechnology. Anti-
4-integrin antibody (mouse anti-rat CD49d monoclonal antibody) and anti-
6-integrin antibody (rat anti-CD49f monoclonal antibody) for functional studies were from Chemicon International. Anti-
4-integrin antibody and anti-ß1-integrin antibody for flow cytometry were from Chemicon International. Horseradish peroxidase (HRP)-conjugated anti-mouse IgG, anti-rat IgG, anti-rabbit IgG and anti-goat IgG were from Jackson Immunoresearch Laboratories (West Grove, PA, USA). Fluorescein isothiocyanate (FITC)-conjugated anti-rat IgG was from Sigma, and Alexa-Fluor-488/goat-anti-mouse-IgG was from Molecular Probes (Eugene, OR, USA).
Purification of MK-binding proteins and sequence analysis
MK-binding membrane proteins were isolated from about 130 g day-13 mouse embryos as described previously (Muramatsu et al., 2000). They were subjected to sodium-dodecyl-sulfate polyacrylamide-gel electrophoresis (SDS-PAGE) under reducing conditions, and their sequences were analysed using a 494A Protein Sequencer (Applied Biosystems, Foster City, CA) after in-gel trypsin digestion and peptide separation (Muramatsu et al., 2000
).
DNA constructs
The coding sequences of human ß1-integrin (Argraves et al., 1987) and human
6-integrin (Tamura et al., 1990
) were ligated into an expression vector pcDNA3.1 (Invitrogen Life Technologies, Carlsbad, CA, USA) with the HA tag sequence at the C-terminus. The coding sequence of human
4-integrin (Takada et al., 1989
) was also ligated into pcDNA3.1 with the FLAG-tag sequence or Myc-tag sequence at the C-terminus. A cDNA encoding the extracellular domain of mouse LRP6 (Brown et al., 1998
; Sakaguchi et al., 2003
) was ligated into pcDNA3.1 with the FLAG-tag sequence at the C-terminus. The cDNA encoding rat PTP
(Maeda et al., 1994
) was inserted into pcDNA3.1.
Cell lines and transfection
COS-7 cells and UMR-106 osteoblastic cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS). For transfection, 5x105 COS-7 cells per 60-mm dish or 1.5x106 cells per 100-mm dish were seeded in DMEM supplemented with 10% FCS. After 24 hours, cells were transfected with pcDNA3.1 with the inserts using LipofectAMINE PLUS reagent or LipofectAMINE 2000 reagent (Invitrogen Life Technologies) for 3 hours according to the manufacturer's protocols.
Binding of integrins to MK
The COS-7 cells transfected with HA-tagged ß1-integrin or 6-integrin or FLAG-tagged
4-integrin cDNA were cultured in DMEM with 10% FCS for 24 hours and lysed in buffer A (20 mM Tris-HCl, pH 7.5, 0.3% CHAPS {3-[(3-cholamidopropyl)dimethylammonio]-propanesulfonic acid}, 0.15 M NaCl, 2 mM CaCl2, 1 mM MgCl2, protease inhibitors). The cell lysate was applied to an MK-agarose column (0.2 ml) equilibrated with buffer A. After washing with buffer A, the column was eluted stepwise with 1 ml of buffer B (20 mM Tris-HCl, pH 7.5, 0.3% CHAPS, protease inhibitor) containing 0.2 M, 0.3 M, 0.4 M and 0.5 M NaCl with or without 20 mM EDTA. The eluate was subjected to SDS-PAGE using a 7% gel under reducing conditions, and the proteins were transferred to a PVDF membrane. The membrane was blocked with 5% nonfat milk in PBS and reacted with anti-HA or anti-FLAG antibody. Then, it was reacted with HRP-conjugated anti-rat IgG or anti-mouse IgG, and bands were revealed using an ECL detection kit (Amersham Biotechnology).
COS-7 cells transfected with 4-integrin/FLAG cDNA were cultured in DMEM supplemented with 10% FCS overnight. The medium was changed to DMEM without L-methionine, L-cysteine or FCS. After 2 hours, 40 µl (20 MBq) L-[35S] methionine [PRO-MIX; L-[35S] in vitro cell labeling mix (Amersham Biosciences)] was added and culture was continued for 40 minutes. Then, the cells were lysed in 1 ml buffer A and the lysate was applied to an anti-FLAG-agarose column (0.4 ml). Material eluted with 2 ml of buffer A containing FLAG peptide (100 µg ml1) was applied to an MK-agarose column. MK-binding proteins were subjected to SDS-PAGE using a 7% gel under reducing conditions, and analysed using an image analyser BAS2000 (Fujifilm, Japan). COS-7 cells were also co-transfected with
4-integrin/FLAG and ß1-integrin/HA, and methionine labeled in the same way. The cell lysate was applied to anti-HA/agarose column. Material eluted with buffer A containing 1 mg ml1 HA-peptide was applied to an MK-agarose column and analysed as above.
Immunoprecipitation
After 24-48 hours of culture, the transfected cells were rinsed with PBS. All the following steps were done on ice or at 4°C using ice-cold buffer. The cells on a 60-mm cell culture plate were covered with 0.5 ml buffer A and scraped with a cell scraper. The cell lysate was transferred to a 1.5 ml microcentrifuge tube, incubated for 20 minutes at 4°C and centrifuged at 10,000 g for 10 minutes to remove cellular debris. The samples were pre-adsorbed with 30 µl Protein-A/agarose or Protein-G/agarose by rotating the sample tubes for 2 hours at 4°C. After centrifugation, 1-10 µl (0.5-5 µg) of primary antibody was added to 0.5 ml of the supernatant fluid and the mixture was incubated at 4°C on a rotating device for between 5 hours and overnight. After addition of 30 µl of Protein-A/agarose or Protein-G/agarose (for anti-HA antibody), the mixture was incubated for 2 hours. The pellet was collected by centrifugation at 3000 g for 3 minutes, washed three times with buffer A and resuspended in 30 µl of 2x electrophoresis sample buffer and subjected to SDS-PAGE and western blotting as mentioned above.
The level of expression of the tagged proteins in the transfected cells were estimated using the [35S]-labeled cells; we determined the percentage of radioactivity immunoprecipitated by an anti-tag antibody to radioactivity precipitated by 10% trichloroacetic acid. The values were 0.03-0.12% for 4,
6, ß1 and LRP6.
For analysis of paxillin phosphorylation, UMR106 cells were cultured without FCS for 8 hours and then incubated with DMEM containing MK for the indicated periods. Cells were lysed in 0.5 ml buffer A containing 0.5 mM sodium vanadate. The cell lysate was immunoprecipitated with anti-paxillin antibody and subjected to western blotting using anti-phosphotyrosine or anti-paxillin antibody.
Assays for cell migration and neurite outgrowth
The migration of UMR106 cells was assayed using Chemotaxicell (Kurabo, Osaka, Japan) with pores 8 µm in diameter, as described previously (Qi et al., 2001). The lower surface of the filter was coated with 20 µg ml1 MK or poly-L-lysine in PBS and 600 µl 0.3% bovine serum albumin (BSA) in DMEM was placed in the lower chamber. UMR-106 cells (1x105) in 100 µl 0.3% BSA/DMEM were added to the upper chamber and incubated for 6 hours. For the inhibition assay, UMR-106 cells were preincubated at room temperature for 30 minutes with antibodies, peptides or IgG, and added to the upper chamber with the inhibitors. Statistical analysis was performed with Student's t test.
A grid assay of neurite outgrowth was performed as described previously (Kaneda et al., 1996), adopting the method described by Rauvala et al. (Rauvala et al., 1994
). Neurite outgrowth on wells coated with 20 µg ml1 MK was performed as described previously (Muramatsu et al., 1993
).
Flow cytometric analysis
The expression of 4 and ß1-integrin on UMR106 cells was analysed by flow cytometry. UMR cells were detached by incubation for 10 minutes at 37°C with non-enzymatic cell dissociation solution (Sigma). The cells (1x106) were washed with PBS and suspended in 1 ml PBS containing 1% BSA. The cell suspension was mixed with 10 µl rat anti-mouse ß1 subunit or mouse anti-rat CD49d, incubated at 4°C on a rotating device for 45 minutes and, after washing with PBS, stained with FITC-conjugated anti-rat IgG or Alexa-Fluor-488/goat anti-mouse IgG at 4°C for 45 minutes. Background fluorescence intensity was assessed in the absence of primary antibody. The expression of integrins were quantified using a Beckman Coulter Flow Cytometer (EPICS XL-2)
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
To examine the binding of ß1-integrin to MK in more detail, we produced HA-tagged ß1-integrin. The cell lysate of COS-7 cells transfected with HA-tagged ß1-integrin cDNA was applied to an MK-agarose column. ß1-Integrin bound to the column at a NaCl concentration of 0.15 M. Under conditions without EDTA, ß1-integrin was mainly eluted by 0.3 M and 0.4 M NaCl, although a significant portion was also eluted by 0.5 M NaCl and part of it remained in the column and was eluted by adding EDTA (Fig. 1A). This strong binding to an MK-agarose column had been observed in the LRP family (Muramatsu et al., 2000; Sakaguchi et al., 2003
) but not in other MK-binding proteins such as PRP-8 (Takahashi et al., 2001
) and NCAM (data not shown). The addition of Mn2+ did not change the elution profile (data not shown). In the presence of EDTA, a large amount of ß1-integrin was eluted without changing the NaCl concentration, and the remainder by 0.2 M and 0.3 M (Fig. 1A). Therefore, ß1-integrin bound specifically to MK and the binding was cation dependent, although the incomplete elution by EDTA indicates that the MK/ß1-integrin interaction is somewhat different from the usual interaction of integrins with proteins in ECM.
|
The subunits of ß1-integrin that bind MK are
4 and
6
Each integrin is a non-covalently linked heterodimer containing one member of the -subunit family and one member of the ß-subunit family. The particular combination of
- and ß-subunits determines the ligand specificity and function of the integrin (Giancotti and Ruoslahti, 1999
; Hynes, 2002
; Kleiman and Mosher, 2002
). Therefore, we tried to identify an
-subunit of ß1-integrin capable of binding to MK, using COS-7 cells and mouse 13-day embryos. Western-blot analysis revealed that COS-7 cells used for the present study strongly expressed
3-,
4-,
5-,
6- and ß1-integrin but neither ß4- nor ß7-integrin. The lysate of COS-7 cells transfected with HA-tagged ß1-integrin or 13-day-old mouse embryos was applied to an MK-agarose column and eluted with 0.5 M NaCl containing EDTA. These eluates, which contained ß1-integrin, were separated by SDS-PAGE and transferred to PVDF membranes, and the membranes were reacted with anti-
3-,
4-,
5- or
6-integrin antibody. Consequently, an 80-kDa fragment from
4-integrin (the anti-
4-integrin antibody recognizes only the 80-kDa fragment of this integrin) and a 130-kDa band of
6-integrin were detected in the transfected COS-7 cells (Fig. 1B), whereas no bands of
3- and
5-integrins were detected. In embryos, only an
6-integrin band was revealed (H.M. and T.M., unpublished).
Based on these results, we transfected cDNAs of HA-tagged 6-integrin and FLAG-tagged
4-integrin into COS-7 cells. The lysate of COS-7 cells transfected with FLAG-tagged
4-integrin was applied to an MK-agarose column and the adsorbed material was eluted with increasing NaCl concentrations.
4-Integrin was mainly eluted with 0.3 M and 0.4 M NaCl, and part of it remained in the column, as in the case of ß1-integrin (Fig. 1C). When the lysate of COS-7 cells transfected with HA-tagged
6-integrin was applied to MK-agarose column and eluted with NaCl, it was also eluted with 0.3 M and 0.4 M NaCl, in a manner similar to ß1-integrin or
4-integrin (Fig. 1D).
We estimated the proportion of integrins bound to the MK column relative to the total amount in the extract by quantifying the amount of HA-tagged or FLAG-tagged integrins by western blotting after SDS-PAGE. In the case of ß1-integrin, 36% bound to the MK column. The values were 39% and 54% for 4- and
6-integrins, respectively. Co-transfection of ß1- and
-subunit cDNAs did not change the result. As an example, when HA-tagged
6-subunit and HA-tagged ß1-subunit cDNAs were transfected, the amount of bound ß1 was 37% of total, and the amount of bound
6 was 49% of total. The elution profile from the column was also unchanged.
To verify that 4-integrin was bound to MK without the help of other molecules,
4-integrin/FLAG was purified using an anti-FLAG-monoclonal-antibody/agarose column and eluted with 100 µg ml1 FLAG peptide. We confirmed the purity of the affinity-purified
4-integrin by using the [35S]-labeled preparation. Upon SDS-PAGE, the major band was about 130-140 kDa, which corresponds to the bands of both
4- and ß1-subunits (Guan and Hynes, 1990
) (Fig. 1E). A minor band of around 70 kDa corresponds to the C-terminal fragment of
4-integrin (Hemler et al., 1987
). The major band was also detected, when FLAG-tagged
4-subunit and HA-tagged ß1-subunit were co-expressed, and
4ß1-integrin was purified by affinity chromatography on anti-HA-antibody/agarose (Fig. 1E). A slight difference of the size of integrin ß1-subunit expressed in COS-7 cells was observed between Fig. 1A and Fig. 1E. We interpret this as showing that, upon overexpression for prolonged period as in Fig. 1A, less glycosylated ß1-subunit is formed. The affinity-purified
4-integrin/FLAG also bound to the MK-agarose column (Fig. 1C) in the same manner as the unpurified one (Fig. 1C).
Because one ligand for 6ß1-integrin is laminin, we also purified
6ß1-integrin using a laminin-1/agarose column before application to the MK column. Although
6ß4-integrin also interact with laminin-1, ß4 was not detected in COS-7 cells. The purified integrin bound to the MK column (Fig. 1D) in a manner indistinguishable from the unpurified one (Fig. 1D). Based on all these results, we concluded that MK bound specifically to
4ß1- and
6ß1-integrins.
4ß1-Integrin is involved in MK-induced migration of osteoblastic cells
MK induces haptotactic migration of UMR-106 rat osteoblastic cells (Qi et al., 2001). Generally speaking, osteoblasts express
2-,
3-,
4-,
5-,
6- and ß1-subunits (Nakayamada et al., 2003
). Western-blot analysis indicated that UMR-106 cells strongly expressed
4ß1-integrin. A weaker expression of the
6-subunit was also noted. Flow-cytometric analysis confirmed that
4ß1-integrin was expressed on the surfaces of these cells (Fig. 2A). It is known that
4ß1-integrin governs the migration of leukocytes to inflammatory sites (Rose et al., 2001
). To evaluate the potential contribution of
4ß1-integrin in MK signaling, we examined whether or not the MK-induced migration of UMR106 cells is mediated by
4ß1-integrin.
|
MK was coated on the lower surface of a filter at a concentration of 20 µg ml1 and the cells were added to the upper chamber. Function-blocking anti-rat-4-integrin antibody inhibited the cell migration in a dose-dependent manner, whereas mouse IgG did not (Fig. 2B). Anti-
6-integrin antibody was not inhibitory (data not shown). Furthermore, the V-10 peptide (GPEILDVPST), which contains the tripeptide of the
4-integrin-binding motif [leucine-asparatate-valine (Guan and Hynes, 1990
)] also inhibited the migration in a concentration-dependent manner. An RGD peptide used as a control was not inhibitory. We confirmed that the V-10 peptide at 1 mg ml1 concentration inhibited the binding of
4ß1-integrin to an MK column to 44% compared with the binding in the absence of the inhibitor. These assays were performed by culturing cells for 6 hours. However, in the assay conducted by culturing cells for 3 hours, anti-
4-integrin antibody inhibited the migration in an identical manner; the antibody at the concentration of 100 µg ml1 reduced the migration to 41% of the control. The result supports our conclusion that the adhesion is to MK and not to other proteins secreted by the cells. Therefore, we concluded that haptotactic migration of UMR-106 cells induced by MK was mediated by
4ß1-integrin.
Anti-6-integrin antibody inhibits MK-dependent neurite outgrowth
When neurons from rat embryonic brains were cultured on the grid pattern of MK formed on culture plates, they attached and extended their neurites along the MK tracks (Kaneda et al., 1996) (Fig. 3A). To examine whether
6-integrin is involved in neurite outgrowth induced by MK, mouse embryonic brains were cultured with anti-
6-integrin antibody. Indeed, anti-
6-integrin antibody inhibited the attachment and neurite outgrowth of neurons on the MK-coated substratum (Fig. 3D), whereas anti-
4-integrin antibody or 0.0045% NaN3 (which is present in the anti-
6-integrin antibody preparation), or mouse IgG did not have this effect (Fig. 3B,C, H.M. and T.M., unpublished).
|
We also performed quantitative analysis of the effect of anti-6 antibody on neurite outgrowth. In the grid assay mentioned above, individual neurons are difficult to observe. Thus, we just plated brain cells on wells coated with MK. Anti-
6 antibody dramatically suppressed the number of cells with extended neurites and increased the number of cells without neurites (Fig. 3E).
MK stimulates tyrosine phosphorylation of paxillin
To further examine the physiological significance of MK-integrin interactions, we investigated whether phosphorylation of integrin-associated molecules is changed after stimulation with MK. Consequently, we found that 200-500 ng ml1 MK transiently increased the tyrosine phosphorylation of paxillin in UMR-106 cells (Fig. 4A). The maximum response was found at 5 minutes after the addition of MK (Fig. 4B). The increase in the phosphorylation was two- to threefold compared with untreated cells. Anti-4 antibody suppressed the increased phosphorylation (Fig. 4C). This finding supports the proposal that the binding of MK to
4ß1-integrins in these cells delivers an intracellular signal necessary for the stimulation of cell migration.
|
6ß1-Integrin is co-immunoprecipitated with LRP6 and PTP
LRP is an important component of the receptor complex for MK (Muramatsu et al., 2000). Therefore, we were interested in clarifying whether LRP forms a complex with
4ß1- or
6ß1-integrin. Because LRP has molecular mass of 600 kDa, it is hard to express by cDNA transfection. We previously found that LRP6, which is a component of the Wnt receptor complex (Tamai et al., 2000
; Wehrli et al., 2000
), binds to MK with similar affinity (Sakaguchi et al., 2003
). Therefore, we decided to investigate this point by transfection of a cDNA for the LRP6 ectodomain. The ectodomain was used to avoid a possible non-specific association of transmembrane proteins.
COS-7 cells were transfected with cDNAs of HA-tagged ß1 (ß1-HA) and FLAG-tagged LRP6 ectodomain (LRP6-FLAG) together, LRP6-FLAG alone or ß1-HA alone. Then, LRP6-FLAG was precipitated with antibody directed against the FLAG epitope, and the immunoprecipitates were probed for the presence of ß1-HA by immunoblotting. As a result, ß1-HA could be detected only in the precipitates from co-transfected cells (Fig. 5A). When ß1-HA was precipitated with anti-HA antibody and the immunoprecipitates were probed for the presence of LRP6-FLAG by immunoblotting, it was detected only in the precipitates from co-transfected cells (Fig. 5B).
|
Identical sets of experiments were performed for 6-integrin. Precipitation of LRP6-FLAG by anti-FLAG antibody co-precipitated
6-HA (Fig. 5C) and precipitation of
6-HA by anti-HA antibody co-precipitated LRP6-FLAG (Fig. 5D). We also examined the association of LRP6 with
4-integrin. COS-7 cells were co-transfected with cDNAs encoding Myc-tagged
4 (
4-Myc) and LRP6-FLAG. After precipitation with anti-Myc antibody, the immunoprecipitates were probed for the presence of LRP6-FLAG by immunoblotting. LRP6-FLAG could be detected only in anti-Myc precipitates from co-transfected COS-7 cells (Fig. 5F). However, precipitation with anti-FLAG antibody and western blotting with anti-Myc antibody revealed no bands (Fig. 5E). Taken together, these results suggested that the LRP6 ectodomain formed a complex with
6ß1-integrin. The LRP6 ectodomain also appears to form a complex with
4ß1-integrin, but further analysis is required to obtain a definitive conclusion.
We also questioned whether the LRP6 ectodomain is co-immunoprecipitated with PTP. PTP
has been identified as a receptor of MK in the MK-dependent migration of UMR-106 osteoblastic cells and embryonic neurons (Maeda et al., 1999
; Qi et al., 2001
). COS-7 was transfected with cDNAs of PTP
and LRP-FLAG. Then, PTP
was precipitated with anti-PTP
antibody and the immunoprecipitates were probed for the presence of LRP6-FLAG by immunoblotting. A 180-kDa band of LRP6-FLAG could be detected only in anti-PTP
precipitates from co-transfected COS-7 cells (Fig. 6A). When LRP6-FLAG was precipitated with anti-FLAG antibody and the immunoprecipitates were probed for PTP
by immunoblotting, a broad band of PTP
could be detected only in the precipitates from co-transfected cells (Fig. 6B).
|
As described here, we suggested that the LRP6 ectodomain formed a complex with 6ß1-integrin and also with PTP
. It is likely that LRP also forms a complex with
6ß1-integrin. Although the distribution of LRP6 is restricted, LRP is expressed in a variety of cells (Herz and Bock, 2002
). Thus, we can infer that
6ß1-integrin and probably
4ß1-integrin form a complex with PTP
when they are co-expressed.
To test this possibility, COS-7 cells were transfected with cDNAs of ß1-HA and PTP, ß1-HA alone or PTP
alone. After precipitation with anti-PTP
antibody, the immunoprecipitates were probed for the presence of ß1-integrin by immunoblotting using anti-HA antibody. Indeed, ß1-HA could be detected only in the precipitates from co-transfected cells (Fig. 7A). When ß1-HA was precipitated with anti-HA antibody and the immunoprecipitates were probed for the presence of PTP
by immunoblotting using anti-PTP
antibody, a broad band of PTP
could be detected only in precipitates from co-transfected cells (Fig. 7B). We also examined the possible association of
6-integrin or
4-integrin with PTP
and obtained the same results (Fig. 7C-F). Although a possible non-specific association through the transmembrane domain could not be completely ruled out in this experiment, the result further supports the proposed presence of a large complex consisting of PTP
, LRP or LRP6 and
4ß1- or
6ß1-integrin. By transfection with cDNAs of
6-HA, LRP6-FLAG and PTP
, we also obtained a result supporting the presence of a complex containing all the three molecules. Thus, the immunoprecipitate pulled down with anti-HA antibody contained both LRP6-FLAG and PTP
(Fig. 6C).
|
Finally, we investigated the proportion of a co-immunoprecipitated tagged molecule to the total tagged molecule expressed in the cells; the value was obtained by western blot analysis of a tagged molecule in the immunoprecipitate and in cell extract. 6-HA co-precipitated with LRP6-FLAG was 7.9% of total
6-HA, and LRP-FLAG co-precipitated with
6-HA was 6.9% of total LRP-FLAG. PTP
co-precipitated with
6-HA was 4.2% of total PTP
. PTP
co-precipitated with LRP6-FLAG was 10% of total PTP
. ß1-HA co-precipitated with LRP6-FLAG was 0.64% of total ß1-HA, and LRP-FLAG co-precipitated with ß1-HA was 0.40% of total LRP6-FLAG. PTP
co-precipitated with ß1-HA was 0.41% of total PTP
. Thus, co-precipitation efficiency of ß1-HA was low and, in other cases, the value was in the range 4-10%. It is likely that the ß1-subunit plays an important role in complex formation and the HA tag hinders the process.
When 200 ng ml1 of MK was added to the culture medium, the proportion of tagged molecules in the co-precipitates of 6-HA and LRP6-FLAG did not increase significantly (data not shown). However, the proportion of ß1-HA co-precipitated with LRP6-FLAG increased about fourfold (Fig. 5G). When the duration of transfection was shortened to lower the expression of
6-HA and LRP6-FLAG,
6-HA co-precipitated with LRP6-FLAG was 2.8% of total
6-HA. On this occasion, 200 ng ml1 of MK increased the co-precipitation of
6-HA about threefold (Fig. 5H). We concluded that exogenous MK increased the efficiency of co-precipitation when the degree of co-precipitation was low in the absence of MK.
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
One ligand of 6ß1-integrin is laminin, another component of the ECM. Laminin is one of the most potent promoters of neurite outgrowth of neuronal cells in culture, and
6ß1-integrin is implicated in neuronal adhesion and neurite outgrowth on laminin (DeCurtis and Reichardt, 1993
). In embryonic neurons, MK promotes neurite outgrowth and migration, and also has anti-apoptotic activity (Muramatsu et al., 1991; Muramatsu et al., 1993
; Michikawa et al., 1993
; Owada et al., 1999
). These effects on embryonic neurons appear to be at least partially mediated by
6-integrin, because MK-induced neurite outgrowth was inhibited by anti-
6-integrin antibody.
We conclude that the binding of MK to 4ß1- and
6ß1-integrins is functionally important. We also provide evidence that purified
4ß1- and
6ß1-integrins bound to MK. In the case of
4ß1-integrin, its purity was confirmed by SDS-PAGE. Because MK also binds to proteoglycans (Kojima et al., 1996
; Maeda et al., 1999
) and LRP (Muramatsu et al., 2000
) with high affinity, it was not possible to determine the binding affinity of MK for integrins directly by measuring the amount of MK bound to cells, which were transfected with integrin cDNAs; future experiments should be directed at determining MK binding to purified integrins. However, the profile of elution from the MK column suggests that MK binds to
4ß1- and
6ß1-integrins with an affinity similar to that of LRP (3.5 nM) (Muramatsu et al., 2000
). From all these results, we have concluded that
4ß1-integrin and
6ß1-integrin are MK receptors.
An interesting question is whether integrins are used in reception of the migratory signal delivered by PTN/HB-GAM, which is closely related to MK (Rauvala, 1989; Li et al., 1990
). It should be mentioned that PTN/HB-GAM also promotes the migration of UMR-106 cells (Imai et al., 1998
). More broadly, the role of the thrombospondin-type-1 repeat in interaction with integrins requires systematic study. The repeat is present in many matrix-bound proteins (such as F-spondin) and has weak but significant homology to the ß-sheet region of PTN/HB-GAM and MK (Kilpelainen et al., 2000
).
There is evidence that PTP (Maeda et al., 1999
; Qi et al., 2001
; Sakaguchi et al., 2003
), LRP family members (Muramatsu et al., 2000
; Sakaguchi et al., 2003
) and ALK (Stoica et al., 2002
) are also MK receptors. Notably, both PTP
(Qi et al., 2001
) and
4ß1-integrin (this study) serve as functional MK receptors mediating the migration of UMR-106 osteoblastic cells. Therefore, a key issue is whether these receptors function separately or as a molecular complex. We analysed this point using an approach similar to that of Borges et al. (Borges et al., 2000
), namely transfection and co-precipitation. To avoid the non-specific association of transmembrane proteins, we used the ectodomain of LRP6. Consequently, we found that
4ß1- or
6ß1-integrin, LRP6 and PTP
were co-immunoprecipitated and were likely to form a receptor complex. This proposal is supported by recent findings that integrins can form a cis association with other receptors on the same cell to form receptor complexes (Schneller et al., 1997
; Porter and Hogg, 1998
; Borges et al., 2000
). The
vß3-integrin associates with PDGF receptor ß, allowing a greater proliferative response to PDGF on vitronectin (Schneller et al., 1997
). Cell adhesion molecule L1 and its close homolog CHL1 also associate with ß1 integrins and enhance integrin-dependent cell migration (Thelen et al., 2002
; Buhusi et al., 2003
).
Generally speaking, a multicomponent receptor will not only increase the affinity of the ligand receptor complex but will also increase the specificity of the recognition. In the case of the MK receptor, co-expression of PTP and
4ß1- or
6ß1-integrin will occur much more rarely than expression of a single component of the receptor. However, studies on multicomponent receptors are still at the initial stage, requiring much more work. In case of the putative MK receptor complex, its existence should be confirmed by a method other than co-immunoprecipitation, especially because the degree of complex formation appeared to be influenced by the density of receptors. The result of the present study suggests that MK stimulates the formation of the receptor complex, when the receptor density is low. Furthermore, it is important to know all molecules constituting the receptor complex.
In this respect, one point that was not explored in the present investigation is the possible role of syndecans in MK signaling. MK binds to syndecans with high affinity (Kojima et al., 1996; Muramatsu, 2002a
) and syndecan-3 has been identified as a receptor of PTN/HB-GAM in neurite outgrowth of embryonic neurons (Raulo et al., 1994
). Furthermore, Src is associated with the cytoplasmic tail of syndecan-3 and ligand binding appears to alter the activity (Kinnunen et al., 1996
). It is still possible that, in certain cases, syndecans might be present in the putative receptor complex and Src is recruited to the complex by association with syndecans.
Whether or not various MK receptors make a molecular complex, we are confident that they co-operate to deliver the MK signal. An increase in tyrosine phosphorylation appears to be a key event after treatment with MK. The requirement of tyrosine phosphorylation for MK-dependent migration of UMR-106 cells was verified in a study using inhibitors (Qi et al., 2001). In contrast to receptor-type tyrosine kinases, PTP
is suggested to be inactivated after ligand binding, enhancing the effect of a competing cytoplasmic kinase (Meng et al., 2000
). Src is an obvious candidate for such a cytoplasmic kinase, because 1[(4-amino-5-(4-methylphenyl)-7(t-butyl)pyrazolo[3,4-D]pyrimidine)] (PP1) inhibits the MK-dependent migration of these cells (Qi et al., 2001
). After an extensive examination of the target of increased tyrosine phosphorylation, we found that MK transiently increased tyrosine phosphorylation of paxillin in UMR-106 osteoblastic cells. Because paxillin is associated with the cytoplasmic tail of integrins (Turner, 2000
; Rose et al., 2002
), the binding of integrins to MK might bring the cytoplasmic portion and paxillin closer to a tyrosine kinase in the receptor complex. Phosphorylated paxillin would stimulate the migration of osteoblastic cells as in the case of bladder tumor cells (Petit et al., 2000
) and normal epithelial cells (Tsubouchi et al., 2002
).
![]() |
Acknowledgments |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Argraves, W. S., Suzuki, S., Arai, H., Thompson, K., Pierschbacher, M. D. and Ruoslahti, E. (1987). Amino acid sequence of the human fibronectin receptor. J. Cell Biol. 105, 1183-1190.[Abstract]
Bokel, C. and Brown, N. H. (2002). Integrins in development, moving on, responding to, and sticking to the extracellular matrix. Dev. Cell 3, 311-321.[Medline]
Borges, E., Jan, Y. and Ruoslahti, E. (2000). Platelet-derived growth factor receptor ß and vascular endothelial growth factor receptor 2 bind to the ß3 integrin through its extracellular domain. J. Biol. Chem. 275, 39867-39873.
Boucher, P., Gotthardt, M., Li, W. P., Anderson, R. G. and Herz, J. (2003). LRP, role in vascular wall integrity and protection from atherosclerosis. Science 300, 329-332.
Brakebusch, C., Bouvard, D., Stanchi, F., Sakai, T. and Fassler, R. (2002). Integrins in invasive growth. J. Clin. Invest. 109, 999-1006.
Brown, S. D., Twells, R. C., Hey, P. J., Cox, R. D., Levy, E. R., Soderman, A. R, Metzker, M. L., Caskey, C. T., Todd, J. A. and Hess, J. F. (1998). Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family. Biochem. Biophys. Res. Commun. 248, 879-888.[CrossRef][Medline]
Buhusi, M., Midkiff, B. R., Gates, A. M., Richter, M., Schachner, M. and Maness, P. F. (2003). Close homolog of L1 is an enhancer of integrin-mediated cell migration. J. Biol. Chem. 278, 25024-25031.
Burns, J. A., Issekutz, T. B., Yagita, H. and Issekutz, A. C. (2001). The 4ß1 (very late antigen (VLA)-4, CD49d / CD29) and
5ß1 (VLA-5, CD49e / CD29) integrins mediate ß2 (CD11 / CD18) integrin-independent neutrophil recruitment to endotoxin-induced lung inflammation. J. Immunol. 166, 4644-4649.
De Curtis, I. and Reichardt, L. F. (1993). Function and spatial distribution in developing chick retina of the laminin receptor 6ß1 and its isoforms. Development 118, 377-388.
Dulabon, L., Olson, E. C., Taglienti, M. G., Eisenhuth, S., McGrath, B., Walsh, C. A., Kreidberg, J. A. and Anton, E. S. (2000). Reelin binds 3ß1 integrin and inhibits neuronal migration. Neuron 27, 33-44.[Medline]
Giancotti, F. G. and Ruoslahti, E. (1999). Integrin signaling. Science 285, 1028-1032.
Guan, J.-L. and Hynes, R. O. (1990). Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor 4ß1. Cell 60, 53-61.[Medline]
Hemler, M. E., Huang, C., Takada, Y., Schwarz, L., Strominger, J. L. and Clabby, M. L. (1987). Characterization of the cell surface heterodimer VLA-4 and related peptides. J. Biol. Chem. 262, 11478-11485.
Henderson, R. B., Lim, L. H. K., Tessier, P. A., Gavins, F. N. E., Mathies, M., Perretti, M. and Hogg, N. (2001), The use of lymphocyte function-associated antigen (LFA)-1-deficient mice to determine the role of LFA-1, Mac-1, and 4 integrin in the inflammatory response of neutrophils. J. Exp. Med. 194, 219-226.
Herz, J. and Bock, H. H. (2002). Lipoprotein receptors in the nervous system. Annu. Rev. Biochem. 71, 405-434.[CrossRef][Medline]
Hood, J. D. and Cheresh, D. A. (2002). Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2, 91-100.[CrossRef][Medline]
Horiba, M., Kadomatsu, K., Nakamura, E., Muramatsu, H., Ikematsu, S., Sakuma, S., Hayashi, K., Yuzawa, Y., Matsuo, S., Kuzuya, M. et al. (2000). Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J. Clin. Invest. 105, 489-495.
Howell, B. W., Herrick, T. M. and Cooper, J. A. (1999). Reelin-induced tyrosine phosphorylation of disabled 1 during neuronal positioning. Genes Dev. 13, 643-648.
Hynes, R. O. (2002). Integrins, bidirectional, allosteric signaling machines. Cell 110, 673-687.[Medline]
Ikematsu, S., Yano, A., Aridome, K., Kikuchi, M., Kumai, H., Nagano, H., Okamoto, K., Oda, M., Sakuma, S., Aikou, T. et al. (2000). Serum midkine levels are increased in patients with various types of carcinomas. Br. J. Cancer 83, 701-706.[CrossRef][Medline]
Imai, S., Kaksonen, M., Raulo, E., Kinnunen, T., Fages, C., Meng, X., Lakso, M. and Rauvala, H. (1998). Osteoblast recruitment and bone formation enhanced by cell matrix-associated heparin-binding growth-associated molecule (HB-GAM). J. Cell Biol. 143, 1113-1128.
Inoh, K., Muramatsu, H., Ochiai, K., Torii, S. and Muramatsu, T. (2004). Midkine, a heparin-binding cytokine, plays key roles in intraperitoneal adhesions. Biochem. Biophys. Res. Commun. 317, 108-113.[CrossRef][Medline]
Iwahara, T., Fujimoto, J., Wen, D., Cupples, R., Bucay, N., Arakawa, T., Mori, S., Ratzkin, B. and Yamamoto, T. (1997). Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene 14, 439-449.[CrossRef][Medline]
Kadomatsu, K., Tomomura, M. and Muramatsu, T. (1988). cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem. Biophys. Res. Commun. 151, 1312-1318.[Medline]
Kaneda, N., Talukder, A. H., Nishiyama, H., Koizumi, S. and Muramatsu, T. (1996). Midkine, a heparin-binding growth / differentiation factor, exhibits nerve cell adhesion and guidance activity for neurite outgrowth in vitro. J. Biochem. 119, 1150-1156.[Abstract]
Kilpelainen, I., Kaksonen, M., Avikainen, H., Fath, M., Linhardt, R. J., Raulo, E. and Rauvala, H. (2000). Heparin-binding growth-associated molecule contains two heparin-binding ß-sheet domains that are homologous to the thrombospondin type I repeat. J. Biol. Chem. 275, 13564-13570.
Kinnunen, T., Raulo, E., Nolo, R., Maccarana, M., Lindahl, U. and Rauvala, H. (1996). Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surface. J. Biol. Chem. 271, 2243-2248.
Kleiman, T. A. and Mosher, D. F. (2002). Integrins. In Wiley Encyclopedia of Molecular Medicine, (ed. Kazazian, H. H., Jr, et al.) pp. 1784-1798. New York: John Wiley and Sons.
Kojima, T., Katsumi, A., Yamazaki, T., Muramatsu, T., Nagasaka, T., Ohsumi, K. and Saito, H. (1996). Human Ryudocan from endothelial-like cells binds basic fibroblast growth factor, midkine, and tissue factor pathway inhibitor. J. Biol. Chem. 271, 5914-5920.
Li, Y. S., Milner, P. G., Chauhan, A. K., Watson, M. A., Hoffman, R. M., Kodner, C. M., Milbrandt, J. and Deuel, T. F. (1990). Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 250, 1690-1694.[Medline]
Maeda, N. and Noda, M. (1998). Involvement of receptor-like protein tyrosine phosphatase /RPTP ß and its ligand pleiotrophin/heparin-binding growth-associated molecule (HB-GAM) in neuronal migration. J. Cell Biol. 142, 203-216.
Maeda, N., Hamanaka, H., Shintani, T., Nishiwaki, T. and Noda, M. (1994). Multiple receptor-like protein tyrosine phosphatases in the form of chondroitin sulfate proteoglycan. FEBS Lett. 354, 67-70.[CrossRef][Medline]
Maeda, N., Nishiwaki, T., Shintani, T., Hamanaka, H. and Noda, M. (1996). 6B4 proteoglycan/phosphacan, an extracellular variant of receptor-like protein-tyrosine phosphatase /RPTP/ß, binds pleiotrophin/heparin-binding growth-associated molecule (HB-GAM). J. Biol. Chem. 271, 21446-21452.
Maeda, N., Ichihara-Tanaka, K., Kimura, T., Kadomatsu, K., Muramatsu, T. and Noda, M. (1999). A receptor-like protein-tyrosine phosphatase PTP/RPTPß binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTP
. J. Biol. Chem. 274, 12474-12479.
Maruyama, K., Muramatsu, H., Ishiguro, N. and Muramatsu, T. (2004), Midkine, a heparin-binding growth factor, is fundamentally involved in pathogenesis of rheumatoid arthritis. Arthritis Rheum. 50, 1420-1429.[CrossRef][Medline]
Meng, K., Rodriguez-Pena, A., Dimitrov, T., Chen, W., Yamin, M., Noda, M. and Deuel, T. F. (2000). Pleiotrophin signals increased tyrosine phosphorylation of ß-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase ß/. Proc. Natl. Acad. Sci. USA 97, 2603-2608.
Michikawa, M., Kikuchi, S., Muramatsu, H., Muramatsu, T. and Kim, S. U. (1993). Midkine is a mediator of retinoic acid induced neuronal differentiation of embryonal carcinoma cells. J. Neurosci. Res. 35, 530-539.[Medline]
Muramatsu, T. (2002a). Midkine and pleiotrophin, two related proteins involved in development, survival, inflammation and tumorigenesis. J. Biochem. 132, 359-371.[Abstract]
Muramatsu, T. (2002b). Midkine. In Wiley Encyclopedia of Molecular Medicine, (ed. Kazazian, H. H., Jr, et al.) pp. 2086-2529. New York: John Wiley and Sons.
Muramatsu, H. and Muramatsu, T. (1991). Purification of recombinant midkine and examination of its biological activities, functional comparison of new heparin binding factors. Biochem. Biophys. Res. Commun. 177, 652-658.[Medline]
Muramatsu, H., Shirahama, H., Yonezawa, S., Maruta, H. and Muramatsu, T. (1993). Midkine (MK), a retinoic acid-inducible growth/differentiation factor, immunochemical evidence for the function and distribution. Dev. Biol. 159, 392-402.[CrossRef][Medline]
Muramatsu, H., Zou, K., Sakaguchi, N., Ikematsu, S., Skuma, S. and Muramatsu, T. (2000). LDL-receptor related protein as a component of the midkine receptor. Biochem. Biophys. Res. Commun. 270, 936-941.[CrossRef][Medline]
Nakayamada, S., Okada, Y., Saito, K., Tamura, M. and Tanaka, Y. (2003). ß1 Integrin/focal adhesion kinase-mediated signaling induces intercellular adhesion molecule 1 and receptor activator of nuclear factor B ligand on osteoblasts and osteoclast maturation. J. Biol. Chem. 278, 45368-45374.
Nurcombe, V., Fraser, N., Herlaar, E. and Heath, J. K. (1992). MK, a pluripotential embryonic stem-cell-derived neuroregulatory factor. Development 116, 1175-1183.
Owada, K., Sanjo, N., Kobayashi, T., Mizusawa, H., Muramatsu, H., Muramatsu, T. and Michikawa, M. (1999). Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons. J. Neurochem. 73, 2084-2092.[Medline]
Petit, V., Boyer, B., Lentz, D., Turner, C. E., Thiery, J. P. and Valles, A. M. (2000). Phosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells. J. Cell Biol. 148, 957-970.
Porter, J. C. and Hogg, N. (1998). Integrins take partners, cross-talk between integrins and other membrane receptors. Trends Cell Biol. 8, 390-396.[CrossRef][Medline]
Qi, M., Ikematsu, S., Maeda, N., Ichihara-Tanaka, K., Sakuma, S., Noda, M., Muramatsu, T. and Kadomatsu, K. (2001). Heptotactic migration induced by midkine. J. Biol. Chem. 276, 15868-15875.
Raulo, E., Chernousov, M. A., Carey, D. J., Nolo, R. and Rauvala, H. (1994). Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3). J. Biol. Chem. 269, 12999-13004.
Rauvala, H. (1989). An 18-kD heparin-binding protein of developing brain that is distinct from fibroblast growth factors. EMBO J. 8, 2933-2941.[Abstract]
Rauvala, H., Vanhala, A., Castren, E., Nolo, R., Raulo, E., Merenmies, J. and Panula, P. (1994). Expression of HB-GAM (heparin-binding growth-associated molecules) in the pathways of developing axonal processes in vivo and neurite outgrowth in vitro induced by HB-GAM. Dev. Brain. Res. 79, 157-176.[Medline]
Rose, D. M., Grabovsky, V., Alon, R. and Ginsberg, M. H. (2001). The affinity of integrin 4ß1 governs lymphocyte migration. J. Immunol. 167, 2824-2830.
Rose, D. M., Han, J. and Ginsberg, M. H. (2002). 4 Integrins and the immune response. Immunol. Rev. 186, 118-124.[CrossRef][Medline]
Sakaguchi, N., Muramatsu, H., Ichihara-Tanaka, K., Maeda, N., Noda, M., Yamamoto, T., Michikawa, M., Ikematsu, S., Sakuma, S. and Muramatsu, T. (2003). Receptor-type protein tyrosine phosphatase as a component of the signaling receptor complex for midkine-dependent survival of embryonic neurons. Neurosci. Res. 45, 219-224.[CrossRef][Medline]
Sato, W., Kadomatsu, K., Yuzawa, Y., Muramatsu, H., Hotta, N., Matsuo, S. and Muramatsu, T. (2001). Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J. Immunol. 167, 3463-3469.
Schaller, M. D. (2001). Paxillin, a focal adhesion-associated adaptor protein. Oncogene 20, 6459-6472.[CrossRef][Medline]
Schneller, M., Vuori, K. and Ruoslahti, E. (1997). vß3 integrin associates with activated insulin and PDGF ß receptors and potentiates the biological activity of PDGF. EMBO J. 16, 5600-5607.
Sengbusch, J. K., He, W., Pinco, K. A. and Yang, J. T. (2002). Dual functions of 4ß1 integrin in epicardial development, initial migration and long-term attachment. J. Cell Biol. 157, 873-882.
Senzaki, K., Ogawa, M. and Yagi, T. (1999). Proteins of the CNR family are multiple receptors for reelin. Cell 99, 635-647.[Medline]
Shibata, Y., Muramatsu, T., Hirai, M., Inui, T., Kimura, T., Saito, H, McCormick, L. M., Bu, G. and Kadomatsu, K. (2002). Nuclear targeting by the growth factor midkine. Mol. Cell. Biol. 22, 6788-6796.
Stoica, G. E., Kuo, A., Aigner, A., Sunitha, I., Souttou, B., Malerczyk, C., Caughey, D. J., Wen, D., Karavanov, A., Riegel, A. T. et al. (2001). Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin. J. Biol. Chem. 276, 16772-16779.
Stoica, G. E., Kuo, A., Powers, C., Bowdon, E. T., Sale, E. B., Riegel, A. T. and Wellstein, A. (2002). Midkine binds to anaplastic lymphoma kinases (ALK) and acts as a growth factor for different cell types. J. Biol. Chem. 277, 35990-35998.
Sumi, Y., Muramatsu, H., Takei, Y., Hata, K., Ueda, M. and Muramatsu, T. (2002). Midkine, a heparin-binding growth factor promotes growth and glycosaminoglycan synthesis of endothelial cells through its action on smooth muscle cells in an artificial blood vessel model. J. Cell Sci. 115, 2659-2667.
Takada, T., Toriyama, K., Muramatsu, H., Song, X.-J., Torii, S. and Muramatsu, T. (1997). Midkine, a retinoic acid-inducible heparin-binding cytokine in inflammatory responses, chemotactic activity to neutrophils and association with inflammatory synovitis. J. Biochem. 122, 453-458.[Abstract]
Takada, Y., Elices, M. J., Crouse, C. and Hemler, M. E. (1989). The primary structure of the 4 subunit of VLA-4, homology to other integrins and a possible cell-cell adhesion function. EMBO J. 8, 1361-1368.[Abstract]
Takahashi, A., Muramatsu, H., Takagi, S., Fujisawa, H., Miyake, Y. and Muramatsu, T. (2001). A splicing factor, Prp8, preferential localization in the testis and ovary in adult mice. J. Biochem. 129, 599-606.[Abstract]
Tamai, K., Semenov, M., Kato, Y., Spokony, R., Liu, C., Katsuyama, Y., Hess, F., Saint-Jeannet, J. P. and He, X. (2000). LDL-receptor related proteins in Wnt signal transduction. Nature 407, 530-535.[CrossRef][Medline]
Tamura, R. N., Rozzo, C., Starr, L., Chambers, J., Reichardt, L. F., Cooper, H. M. and Quaranta, V. (1990). Epithelial integrin 6ß4: complete primary structure of
6 and variant forms of ß4. J. Cell Biol. 111, 1593-1604.[Abstract]
Thelen, K., Kedar, V., Panicker, A. K., Schmid, R. S., Midkiff, B. R. and Maness, P. F. (2002). The neural cell adhesion molecule L1 potentiates integrin-dependent cell migration to extracellular matrix proteins. J. Neurosci. 22, 4918-4931.
Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., Hammer, R. E., Richardson, J. A. and Herz, J. (1999). Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97, 689-701.[Medline]
Tsubouchi, A., Sakakura, J., Yagi, R., Mazaki, Y., Schaefer, E., Yano, H. and Sabe, H. (2002). Localized suppression of RhoA activity by Tyr31/118-phosphorylated paxillin in cell adhesion and migration. J. Cell Biol. 159, 673-683.
Turner, C. E. (2000). Paxillin and focal adhesion signaling. Nat. Cell Biol. 2, E231-E236.[CrossRef][Medline]
Watt, F. M. (2002). Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J. 21, 3919-3926.
Wehrli, M., Dougan, S. T., Caldwell, K., O'Keefe, L., Schwartz, S., Vaizel-Ohayon, D., Schejter, E., Tomlinson, A. and DiNardo, S. (2000). Arrow encodes an LDL-receptor-related protein essential for Wingless signaling. Nature 407, 527-530.[CrossRef][Medline]